| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 湖南景峰医药股份有限公司主营业务医药产品的研发、制造与销售。 公司专注医药健康产业，涉足药品研发、生产、销售等领域，产品涵盖了心脑血管、抗肿瘤、骨科、妇儿等用药领域。目前公司拥有大容量注射剂、小容量注射剂（含抗肿瘤类）、冻干粉针剂（含抗肿瘤类）、注射乳剂、硬胶囊剂、丸剂、颗粒剂、气雾剂、酊剂、口服乳、中药饮片以及原料药等通过国家GMP认证的生产线二十余条。除此之外，有数条原料药生产线通过了中国NMPA认证。 多年来，公司坚持“走与国际接轨的仿制药产业化道路”战略，实施以高壁垒仿制药为主、长短结合、多维研发生产管线并进的战略布局。 | ||||||||||||||||||||||||
| Main Business | 医药产品的研发、制造与销售。 | ||||||||||||||||||||||||
| Legal Representative | 叶湘武 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 毕元 | ||||||||||||||||||||||||
| Solicitors | 北京市中伦律师事务所 | ||||||||||||||||||||||||
| Auditors | 立信会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0736-7320908 | ||||||||||||||||||||||||
| Fax No | 0736-7320908 | ||||||||||||||||||||||||
| Website | www.jfyiyao.com | ||||||||||||||||||||||||
| ir@jfzhiyao.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 03/02/1999 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -0.245 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ -0.056 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 1.475B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |